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Summary. The types of nuclear data and their quality
required in the production and application of diagnostic ra-
dionuclides are outlined. The radioactive decay data determine
the suitability of a radioisotope for in vivo tracer studies, both
from the imaging and internal radiation dose considerations.
The nuclear reaction cross section data allow optimisation
of production routes. Both reactors and cyclotrons are used
for production purposes. The nuclear data needed in the two
cases and their present status are discussed. Special attention
is paid to radionuclides suitable for emission tomography
(PET and SPECT). The controversy about reactor vs cy-
clotron production of the widely used 99Mo/99mTc generator
system is discussed. Some special considerations in cyclotron
production of radionuclides are outlined. The need of accu-
rate data near reaction thresholds, the constraint of available
particles and their energies at a small cyclotron, the influence
of increasing incident particle energy, and the formation of
isomeric impurities are discussed in detail. The role of nuclear
model calculations in predicting unknown data is considered.
1. Introduction
A medically related radioisotope is classified as a diagnostic
or a therapeutic radionuclide, depending on its decay prop-
erties. In this article the diagnostic radioisotopes in general,
and their production data in particular, are treated. The major
criteria for diagnostic use are:
– suitable physical properties, i.e. a high detection efficiency
for the radionuclide, compatible with the lowest possible
radiation dose to the patient
– suitable biochemical properties, especially organ selectiv-
ity and comptability with the bio-kinetics.
As far as physical properties are concerned, the half-life
should be short (between a few minutes and a few hours) and
the decay should occur preferably via IT, EC or β+ emission.
Furthermore, the specific radioactivity of the final product
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should be rather high. In general, the diagnostic radioiso-
topes are classified into two groups, namely γ -emitters (e.g.
67Ga, 111In, 201Tl, etc.) and β+ emitters (e.g. 15O, 18F, etc.).
If the radioisotope emits a single γ -ray, the detection tech-
nique called Single Photon Emission Computed Tomogra-
phy (SPECT) can be used; in the case of β+ emitters, the
use of Positron Emission Tomography (PET) is very advan-
tageous. The two techniques (SPECT and PET) are often
collectively termed as emission tomography. By virtue of
its quantitative nature, rapidity and higher resolution, PET
is superior to SPECT. However, the latter finds much wider
use due to considerably lower costs of radionuclides, instru-
mentation and operation. A detailed description of the two
diagnostic techniques is given elsewhere in this issue (cf.
contribution by Herzog).
The biochemical properties have little relevance to nu-
clear data. They depend upon the functional group of the
molecule to which the radioisotope has been attached.
Evidently, for fast biochemical phenomena, like glucose
or oxygen uptake, short-lived radioisotopes are suitable,
whereas for slower processes, like protein synthesis, some-
what longer-lived radioisotopes are needed.
2. Radioactive decay data: internal radiation
dose calculation
As mentioned above, the physical properties determine the
choice of a radioisotope for medical application. In internal
radiation dose calculation, i.e. calculation of the dose to an
organ delivered by the administered radionuclide, however,
both decay data and biological behaviour of the compound
labelled with the radioisotope need to be considered. The ef-
fective half-life of the radiopharmaceutical in the organ is
thus a combination of the physical half-life and the biolog-
ical half-life.
The available information on decay data is extensive, at
least for the most commonly used PET and SPECT radioiso-
topes. The types of data needed in internal radiation dose
calculations have been outlined (cf. Introductory chapter by
Qaim). The methods of internal dose calculation have re-
ceived extensive attention and well-known computer codes,
known as MIRD codes, are now available. A discussion of
the dose calculation in diagnostic studies using PET and
SPECT is given elsewhere is this issue (cf. contribution by
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Herzog on this topic). Here it needs to be pointed out that
the criterion of minimum dose in diagnostic studies puts
a heavy demand on the radionuclidic purity of the radio-
pharmaceutical. If some impurity is present, especially hav-
ing a long half-life and emitting corpuscular radiation, it
will lead to additional radiation dose. Thus the production
method should be chosen such that the product radionuclide
contains the lowest possible impurity. In general, the iso-
topic impurities are controlled by a selection of the relevant
production data, and the non-isotopic impurities by a clean
chemical separation. The MIRD calculations are generally
based on the assumption that the radionuclide under consid-
eration is of the highest possible purity.
In recent years, accurate dosimetric considerations have
demanded a more detailed information on the low energy
but high intensity corpuscular radiation (such as conversion
and Auger electrons) associated with some diagnostic ra-
dionuclides (e.g. those decaying by EC or IT). This low
energy radiation is not detectable with the instrumentation
used in nuclear medicine but causes additional dose. Some
new efforts are therefore under way to examine conversion
coefficients of nuclear transitions related to SPECT radioiso-
topes.
3. Nuclear reaction cross sections and production
yields
The nuclear reaction cross sections are of considerable im-
portance in optimising the production process of a radioiso-
tope (cf. Introductory chapter by Qaim). In principle, the
well-known activation equation is applicable to all activation
processes, whether induced by neutrons or charged particles.
In practice, however, there are distinct differences since
the neutrons generally show a spectral distribution whereas
the charged particles rapidly lose energy while traversing
a medium. In the following, the nuclear data relevant to the
production of radioisotopes in a reactor and at a cyclotron
are discussed separately.
3.1 Production of radioisotopes in a nuclear reactor
3.1.1 Nuclear reactions
The production of radionuclides in a nuclear reactor has
been under constant review for the last four decades [cf. 1].
In this article mainly the nuclear data aspects are considered.
The relevant nuclear processes are described below.
(n, γ) reaction
This is the most commonly occurring reaction in a nu-
clear reactor. Since no reaction threshold is involved, this
process can be induced by thermal, epithermal as well
as fast neutrons, although in general the cross section is
most relevant for thermal neutrons. A few examples of ra-
dioisotopes produced via this method are given in Table 1.
Among them are 99Mo, 125Xe and 131m,gTe, the parents of
the commonly used radionuclides 99mTc, 125I and 131I, re-
spectively. The major advantage of the procedure lies in
the simple methodology, and the main disadvantage in the
low specific radioactivity. The latter is improved to some
extent via Szilard-Chalmer´s process or via generator prep-
aration, i.e. by using the decay product of an (n, γ) reaction
product.
Inelastic scattering
In recent years a few isomeric states have been activated
via the (n, n′γ ) process, especially those having high nu-
clear spins. Some of those radionuclides, for example 117mIn,
119mSn and 195mPt are produced in higher specific radioactiv-
ity via the (n, n′γ ) process than via the (n, γ) reaction [cf. 2].
Sequential neutron capture
Occasionally a radioisotope may be produced via a sequen-
tial capture of two neutrons (cf. Table 1). The process is,
however, of limited use since it occurs only in a high flux re-
actor. It appears to be of special advantage in the region of
rare earths where the neutron capture cross sections are very
high.
(n, fission) process
Like the (n, γ) reaction, it is also a commonly used
process. In general, products lying on one of the two
mass-yield peaks of the fission process can be advanta-
geously produced. Two very important medical radionu-
clides, namely 99Mo and 131I, are produced via the fission
of 235U (cf. Table 1). The method is of great advantage and
leads to no-carrier-added products, i.e. products of very high
specific radioactivity. The main disadvantage, however, is
the extensive chemical processing involved.
(n, z) process
The emission of charged particles in neutron induced reac-
tions is also utilized to produce some special radioisotopes.
In general, these reactions occur only in the light mass re-
gion where the reaction thresholds are low and the compe-
tition between charged particle and neutron emission is in
favour of the former. Some examples are given in Table 1.
The method is of considerable advantage since the prod-
ucts are of high specific radioactivity. The cross sections are,
however, generally low, except for the formation of tritium
and 14C. The latter two radionuclides are almost exclusively
produced via the (n, z) process.
Secondary reactions
In certain cases the charged particle emitted in a nuclear
reaction may induce a secondary reaction on a neighbour-
ing nucleus. Two such cases are mentioned in Table 1. The
production of 18F via the reaction sequence 6Li(n, α)3H →
16O(t, p)18F had been in use for quite some time. The major
problems were the relatively low yields of 18F and presence
of tritium impurity. In recent years the cyclotron production
of 18F has completely superseded its production in a reactor.
Similarly, 28Mg production is now also done more com-
monly at a medium-energy cyclotron.
It is understood that the use of a secondary reaction in
medical radionuclide production demands a careful consid-
eration of the cross section of the primary reaction, the en-
ergy spectrum of the emitted charged particle, as well as the
Nuclear data relevant to the production and application of diagnostic radionuclides 225
Table 1. Commonly used nuclear reactions for the production of some radioisotopes in a nuclear reactor.
Radio- T1/2 Mode of decay Main γ -ray energy Production reaction Cross section
nuclide (%) in keV (%) in barn∗
(n,γ ) reaction
24Na 15.0 h β− (100) 1369 (100) 23Na(n, γ ) 0.53
2754 (99.9)
32P 14.3 d β− (100) 31P(n, γ ) 0.18
35S 87.5 d β− (100) 34S(n, γ ) 0.29
42K 12.4 h β− (100) 1525 (18.8) 41K(n, γ ) 1.46
51Cr 27.7 d EC (100) 320 (9.8) 50Cr(n, γ ) 15.90
64Cu 12.7 h β+ (18); EC (45); 63Cu(n, γ ) 4.50
β− (37)
75Se 119.8 d EC (100) 136 (59.0) 74Se(n, γ ) 46.00
265 (59.2)
401 (11.6)
99Mo 66.0 h β− (100) 140 (90.7) 98Mo(n, γ ) 0.13
740 (12.1)
125Xe 16.9 h β+(0.7); EC (99.3) 188 (54.9) 124Xe(n, γ ) 165.00
243 (28.8)
131m,gTe† 30.0 h IT (22); β+ (78) 774 (38.1) 130Te(n, γ ) 0.23
25.0 min β− (100) 150 (68.9)
153Sm 46.3 h β− (100) 103 (28.3) 152Sm(n, γ ) 206.00
186Re 89.2 h β− (92.2); EC (7.8) 137 (8.5) 185Re(n, γ ) 114.00
Sequential neutron capture
32Si 172.0 a β− (100) 30Si(n, γ ) 31Si(n, γ ) 0.11; 0.3
(2.6 h)
166Dy† 81.5 h β− (100) 82 (13.0) 164Dy(n, γ )165Dy(n, γ ) 2700; 3500
(2.4 h)
188W† 69.0 d β− (100) 291 (0.4) 186W(n, γ )187W(n, γ ) 36;70
(23.7 h)
(n, fission) process
90Sr† 28.6 a β− (100) 235U(n, f ) Ycum: 5.89%
99Mo† —————————————— see above —————————————— 235U(n, f ) Ycum: 6.14%
131I 8.0 d β− (100) 364 (81.2) 235U(n, f ) Ycum: 2.84%
637 (7.3)
(n, z) reaction
3H 12.3 a β− (100) 6Li(n, α) 940
14C 5730 a β− (100) 14N(n, p) 1.8
32P —————————————— see above —————————————— 32S(n, p) 0.07
35S —————————————— see above —————————————— 35Cl(n, p) 0.08
37Ar 35.0 d EC (100) 40Ca(n, α) 0.03
Secondary reactions
18F 109.6 min β+ (97); EC (3) 6Li(n, α)3H → 16O(t, p)18F
28Mg 20.9 h β− (100) 401 (36) 6Li(n, α)3H → 26Mg(t, p)28Mg
1342 (54)
∗ Capture cross sections as well as the 6Li(n, α) and 14N(n, p) cross sections are for thermal neutrons. Other (n, z) cross sections are fission neutron
spectrum averaged values. The fission yields are cumulative yields (Ycum). For the secondary reactions only production yields have been reported
in the literature.
† Decay products are of interest: 90Sr → 90Y; 99Mo → 99mTc; 131m,gTe → 131I; 166Dy → 166Ho; 188W → 188Re.
absorption profile of the particle in the surrounding medium.
A chemical compound or an alloy form is very suitable for
production purposes, for example, Li2CO3 to produce 18F
and Li/Mg alloy to produce 28Mg.
3.1.2 Chemical processing and applications
Though only indirectly related to the problem of nuclear
data, a brief mention should be made of the techniques and
methods used to obtain the desired radionuclide in a suitable
form after activation in a nuclear reactor. In general, after the
irradiation, an extensive chemical processing is mandatory,
especially if the fission process is utilized for production
purposes. The demands on the purity are very stringent, par-
ticulary with regard to the content of α-emitting impurities.
An example is the separation of 99Mo from 235UAl3 -alloy.
The chemically separated 99Mo is used to prepare a gener-
ator system. This consists of loading the 99Mo activity on
an Al2O3 column and milking off the decay product 99mTc
periodically by elution with saline.
It is worth mentioning that the 99Mo/99mTc gener-
ator is the most commonly used system in diagnostic
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nuclear medicine. Due to the ideal imaging properties
of 99mTc with SPECT, about 80% of all nuclear med-
ical procedures are performed worldwide with it. The
generator form makes the availability of 99mTc easy; its
specific radioactivity is very high. The product is used
directly for labelling biomolecules. In fact several kits
have been developed which require a simple addition of
the eluted saline containing 99mTc to obtain a particular
radiopharmaceutical.
As far as nuclear data are concerned, constructing a gen-
erator system demands a good knowledge of the decay
properties of the two radioisotopes concerned. In particu-
lar, the half-lives are important, but the shielding require-
ments also demand a knowledge of the corpuscular and
electromagnetic radiation emitted in the decay of the two ge-
netically related radioisotopes as well as the impurities, if
any.
Many of the reactor-produced corpuscular radiation emit-
ting radionuclides are used in therapy (cf. contribution by
Qaim on this topic, this issue). Some radioisotopes find ap-
plication in tracer studies related to industrial processes,
radioagronomy and enviromental phenomena. The soft radi-
ation emitting radionuclides 3H, 14C and 125I are extensively
used in investigations involving in vitro methods.
3.1.3 Status of production cross sections
The status of neutron induced reaction cross sections is gen-
erally good, mainly due to the energy-related programmes.
Data on the three types of processes commonly used in
medical radioisotope production, viz. (n, γ), (n,fission) and
(n, z), are well compiled [cf. 3–6], well evaluated using nu-
clear model calculations [cf. 7–9], and well documented
(see e.g. contribution by Schwerer and Oblozinsky, this
issue). For many reactions, data validation has also been
performed by comparing integral yield measurements in
a fission spectrum with those integrated from the meas-
ured (n, x)-excitation functions (for a fission spectrum
distribution).
For the less commonly used (n, n′γ ) and double neutron
capture processes, it is occasionally necessary to perform
new measurements or to evaluate the existing data, espe-
cially if they show large discrepancies.
Classification Characteristics Energy Major radionuclides produced
[MeV]
Level I single particle ∗ < 4 15O
(d)
Level II single particle ≤ 11 11C, 13N, 15O, 18F
(p)
Level III single or two particle ≤ 20 11C, 13N, 15O, 18F
(p, d) (123I, 67Ga, 111In)
Level IV single or multiple particle ≤ 40 38K, 73Se, 75−77Br, 123I, 81Rb (81Kr),
(p, d,3He,4He) 67Ga, 111In, 201Tl, 22Na, 57Co
Level V single or multiple particle ≤ 100 28Mg, 72Se (72As),
(p, d,3He,4He) 82Sr (82Rb),117mSn, 123I
Level VI single particle ≥ 200 26Al, 32Si, 44Ti, 67Cu, 68Ge (68Ga),
(p) 82Sr (82Rb), 109Cd, 95mTc, etc.
∗ A small linear two particle accelerator (p, d) has also been suggested.
Table 2. Types of accelerators routinely
used for radioisotope production.
3.2 Production of radioisotopes at a cyclotron
The production of radioisotopes at cyclotrons has been ex-
tensively discussed in many review articles, monographs and
books. A critical analysis of the nuclear data problems was
first done at Jülich [10]. The emphasis in this section of the
present article is on new aspects of nuclear data research rel-
evant to cyclotron production of radionuclides.
3.2.1 Cyclotrons for applications
Over the last two decades, several types of cyclotrons and
accelerators have been developed to meet the specific de-
mands of radionuclide production; a summary is given in
Table 2. The presentation is an updated form of an ear-
lier classification [11]. The smallest accelerator is a single
particle machine with Ed ≤ 4 MeV, i.e. below the breakup
threshold of the deuteron (to avoid neutron background). It
is used exclusively in a hospital environment to produce 15O.
The next stage accelerator is also a single particle negative
ion machine with Ep ≤ 11 MeV or 12 MeV and can be used
to produce the four major β+ emitters, viz. 11C, 13N, 15O
and 18F, although the absence of the deuteron beam is some-
what disadvantageous regarding the production of 15O, and
the rather low proton energy gives low yield of 13N. The
next higher group of machines is generally a two particle
machine with Ep ≤ 20 MeV and Ed ≤ 10 MeV. It is ideally
suited for the production of commonly used PET radio-
isotopes. The higher energy machines have capabilities of
producing many more radioisotopes, in particular when be-
sides p and d, also 3He and α-particle beams are available.
On the other hand, when energies above 100 MeV are under
consideration, only the proton beam is of interest.
3.2.2 Cyclotron products and data needs
In diagnostic studies, the cyclotron products exhibit con-
siderable advantages over the reactor products. The specific
radioactivity is high and the radiation dose is low. Further-
more, they are often more suitable for emission tomogra-
phy. Since in many cases they may be easily attached to
a biomolecule, they are very useful for investigating regional
physiological functions.
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Radionuclide T1/2 Mode of Main Production data
decay γ -ray
energy Nuclear Energy Thick target
(%) in keV (%) reaction∗ range (MeV) yield
MBq(mCi)/µA ·h
11C 20.4 min β+ (99.8) 511 (199.6) 14N (p, α) 13 → 3 3820 (103)
EC (0.2)
13N 10.0 min β+ (100) 511 (200) 16O (p, α) 16 → 7 1665 (45)
15O 2.0 min β+ (99.9) 511 (199.8) 14N (d, n) 8 → 0 2368 (64)
EC (0.1) 15N (p, n) 10 → 0 2220 (60)
18F 109.6 min β+ (97) 511 (194) 18O (p, n) 16 → 3 2960 (80)
EC (3) 20Ne (d, α) 14 → 0 1110 (30)
68Ge 271 d EC (100) RbBr (p, spall) 800, 500 0.15 (0.0004)
↓ (generator) 69Ga (p, 2n)
68Ga 68 min β+ (90) 511 (180)
EC (10) 1077 (3)
82Sr 25 d EC (100) Mo (p, spall) 800 3.7 (0.1)
↓ (generator) 85Rb (p, 4n) 60 → 40 14.8 (0.4)
82Rb 1.3 min β+ (96) 511 (192)
EC (4) 776 (13.4)
∗ Evaluated excitation functions of all the reactions listed here (except the spallation process) are now available
in [14]. The yields given here are generally in agreement with those reported in [14].
Table 3. Routine methods
of production of some
commonly used positron
emitters [cf. 12, 13].
Due to a variety in the available charged particles and the
broad spectrum of energies involved, the nuclear data needs
in cyclotron production of radioisotopes are much more in-
tense than those in reactor production. Some salient groups
of radionuclides are treated in detail below.
Positron emitters
Most of the PET studies to date are carried out with the
four short-lived organic positron emitters, viz. 11C(T1/2 =
20 min), 13N(T1/2 = 10 min), 15O(T1/2 = 2 min) and 18F(T1/2 =
110 min). The former three radionuclides are generally used
on site of production. 18F, on the other hand, is suitable for
transport to nearby PET centres without a cyclotron. There
is also considerable interest in 68Ga(T1/2 = 68 min) and
82Rb(T1/2 = 1.3 min), which are obtained via longer-lived
generator parents. The routine production methods of the
commonly used β+ emitters are summarized in Table 3 [cf.
12, 13].
The organic β+ emitters are generally produced using
low energy nuclear reactions like (p, n), (p, α), (d, n), (d, α),
etc. and a small-sized cyclotron is adequate for production
purposes. The excitation functions have been measured in
several laboratories. The cross sections show strong fluc-
tuations, probably due to the population of known discrete
levels of the product nucleus. The nuclear model calcula-
tions cannot a priori describe such excitation functions. In
a recent attempt to evaluate the existing data under the aus-
pices of an IAEA-CRP [14], therefore, only statistical fitting
procedures were employed. The recommended curve for the
16O(p, α)13N reaction, taken from [14], is shown in Fig. 1 as
an example. The integated yields of the products calculated
from the excitation functions, however, show smooth curves,
i.e. in the production process the nuclear structure effects are
washed out [12].
Several β+ emitting radiopharmaceuticals are now rou-
tinely used in diagnostic nuclear medicine [cf. 13]. Of ma-
jor interest is the product 2-[18F]fluoro-2-deoxy-D-glucose,
commonly known as FDG. Its synthesis was developed
at Jülich [15]. Curie amounts of this radiopharmaceutical
are now available using automated synthesizers. The clini-
cal applications of several PET tracers are discussed else-
where in this issue (cf. contribution by Herzog on functional
imaging).
The generator produced β+ emitters find application
mostly in PET studies at centres without a cyclotron. The
parent isotopes of the two most commonly used systems (see
Table 3), namely 68Ge and 82Sr, are rather difficult to pro-
duce. Although cross section data on the relevant (p, xn) re-
actions have been measured and also recently evaluated [14],
due to targetry problems, in both cases the method of choice
is the spallation process [cf. 16, 17]. The production yields
are known.
The number of potentially interesting longer-lived re-
search related β+ emitters is relatively large, but their rela-
tive importance keeps on changing. The production of those
radionuclides often demands larger cyclotrons. In many
Fig. 1. Excitation function of the 16O(p, α)13N reaction. Data adopted
from [14].
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Radionuclide T1/2 Mode of Main Production data
decay γ -ray
energy Nuclear Energy Thick target
(%) in keV (%) reaction∗ range (MeV) yield
MBq(mCi)/µA ·h
67Ga 3.26 d EC (100) 93 (37) 68Zn (p, 2n) 26 → 18 185 (5)
185 (20) (199.6) 67Zn (p, n)
99Mo 2.75 d β− (100) 181 (6) 235U (n, f ) a
↓ (generator) 740 (12) 98Mo (n, γ ) b
99mTc 6.0 h EC (100) 141 (87)
111In 2.8 d EC (100) 173 (91) 112Cd (p,2n) 25 → 18 166 (4.5)
247 (94) 111Cd (p,n)
123I 13.2 h EC (100) 159 (83) 123Te (p,n) 14.5→ 10 137 (3.7)
124Te (p,2n) 26 → 23 392 (10.6)
127I (p, 5n)123Xe c 65 → 45 777 (21) d
124Xe (p, x)123Xe c 29 → 23 414 (11.2) d
201Tl 3.06 d EC (100) 69−82 201Tl (p, 3n)201Pb e 28 → 20 18 (0.5) f
(X-rays)
166 (10.2)
∗ Evaluated excitation functions of all the reactions listed here (except the neutron induced reactions) are now
available in [21]. The yields given here are generally in agreement with those reported in [21].
a: TBq (hundreds of Ci) amounts of this radioisotope are produced at centres with well-developed technology.
b: Method used in less-developed laboratories.
c: 123Xe decays by EC (87%) and β+ emission (13%) to 123I.
d: This is 123I yield expected from the decay of 123Xe over an optimum time of about 7 h.
e: 201Pb decays by EC (100%) to 201Tl.
f: This is 201Tl yield expected from the decay of 201Pb over an optimum time of 32 h.
Table 4. Routine methods
of production of some
commonly used photon
emitters [10, 13].
cases machines accelerating four particles, viz. p, d, 3He and
α-particles, have proven to be very versatile. Evidently, the
development of a production process involves considerable
amount of nuclear data work.
Photon emitters
A large number of γ -ray emitting radionuclides have found
application in diagnostic nuclear medicine using either γ -
cameras or, in recent years, SPECT. The most commonly
used SPECT radionuclide 99mTc (T1/2 = 6.0 h) is produced
using a nuclear reactor (see above). Several other SPECT ra-
dionuclides, produced at a cyclotron, are listed in Table 4.
All of them need a medium-sized cyclotron, although in
some cases (e.g. 67Ga, 111In and 123I) low-energy ma-
chines capable of inducing (p, n) reactions have also been
used [18–20]. The nuclear reaction cross section data for
most of the processes are known and have been recently
evaluated, using both nuclear model calculations and fit-
ting methods [21]. Surprisingly the data for the commonly
employed 124Xe(p, x)-process for the production of 123I,
a widely used SPECT radionuclide, are still discrepant.
3.2.3 On the possibility of accelerator production of
99Mo/99mTc
There has been some apprehension regarding the con-
tinued availability of the most commonly used SPECT
radionuclide 99mTc. With the closure of ageing nuclear
reactors, the supply of 99Mo, the parent of 99mTc, may
be jeopardised. Some thoughts were therefore devoted to
a possible production of 99Mo and 99mTc at a cyclotron.
In a report Lagunas-Solar et al. even claimed [22] that
medium-sized cyclotrons could partly or wholly replace
Fig. 2. Excitation function of the 100Mo(p, 2n)99mTc reaction. Diagram
taken from [23]. The strong peak at about 42 MeV reported in [22] was
not observed by authors of [23], who used highly enriched 100Mo as
target material.
reactors, as far as the production of 99Mo/99mTc is con-
cerned. This claim was based on the exceptionally high
98Mo(p, γ )99mTc and 100Mo(p, 2n)99mTc reaction cross sec-
tions found by them. Under an IAEA-sponsored study,
done mostly at Jülich, Scholten et al. [23] performed some
key measurements using several cyclotrons. The cross sec-
tion of the 98Mo(p, γ )99mTc reaction was found to be
negligibly small (< 0.2 mb) over the whole investigated
energy range of 6 to 45 MeV, and the results of meas-
urements on highly enriched 100Mo are given in Fig. 2.
The peak in the cross section at about 17 MeV is due
to the 100Mo(p, 2n)99mTc reaction. This was attributed by
Lagunas-Solar et al wrongly to the 98Mo(p, γ )99mTc pro-
cess. The second strong peak at about 42 MeV reported by
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Lagunas-Solar et al. could not be observed in the work
of Scholten et al. [23]. Presumbly it was due to some
impurity. The study of Scholten et al led to the conclu-
sion that 99mTc can be produced at a cyclotron in small
amounts for local use only. The amount of 99Mo produced
is small and its specific radioactivity rather low. There is
thus no substitute for reactor produced 99Mo/99mTc genera-
tors. Some recent measurements done with deuterons under
a Debrecen/Brussels cooperation lead to a somewhat similar
conclusion.
In the meantime the situation has rather eased off since
some new facilities for production of fission 99Mo have been
established. Nonetheless, the results quoted above and the
discussion based on them demonstrate the importance of
accurate cross section measurements. Inaccurate and unreli-
able data can lead to erroneous interpretations and unneces-
sary controversies.
Despite the above mentioned negative remarks regarding
the possibility of 99mTc production at a small- or medium-
sized cyclotron, it should be pointed out that the accelera-
tor production of 99Mo/99mTc is not completely uninterest-
ing. If a high-energy proton accelerator would be available,
that could be utilized to produce spallation type neutrons,
the fission of 235U could be used to produce 99Mo in large
quantities.
3.2.4 Some special considerations in nuclear data studies
In research and development work relevant to production of
radioisotopes at a cyclotron, following aspects need to be
taken into account.
Search for alternative production routes
The development of an alternative production route may be
necessary due to one or more of the following reasons:
(i) availability of a single accelerated particle at the cy-
clotron and constraint of its energy
(ii) demand on higher yield and purity of the product
(iii) demand on higher specific radioactivity.
A few examples are given in Table 5. In those and many
other cases an alternative production route demands the
use of a highly enriched target isotope whose natural
abundance may be very low. The development of the
124Xe(p, x)123Xe → 123I process demonstrates the changing
Radio- Common Alternative Natural Enrichment Reason for
nuclide production production abundance used alternative
route route of target (%) (%) route
15O 14N (d, n) 15N (p, n) 0.37 99
Small-sized
18F 20Ne (d, α) 18O (p, n) 0.20 98


cyclotron with
only p beam
38K 35Cl (α, n) 38Ar (p, n) 0.06 96
123I 124Te (p, 2n) 124Xe (p, x)123Xe → 0.10 99.9 Demand on
127I (p, 5n)123Xe → purity
186Re 185Re (n, γ ) 186W (p, n) 28.60 99.8 Demand on
high specific
activity
Table 5. Development of alterna-
tive production routes.
demands on the quality of the medically important radionu-
clides. The natural abundance of 124Xe is only about 0.1%;
consequently the highly enriched 124Xe is very expensive.
What has become a common production technique today,
was not imaginable about 20 years ago.
Need of accurate data near reaction thresholds
With the increasing use of low-energy cyclotrons in med-
ical radioisotope production programmes, the importance
of cross section data near reaction thresholds has en-
hanced. Many of the older data are based on excitation
function measurements in which the incident particle en-
ergy was rather high. Due to energy degradation in the
stacks over large spans, the experimental cross section
data near the reaction thresholds may be inaccurate. The
theory may provide here some guidance since the thresh-
old is calculated rather accurately in comparison to the
maximum cross section. A good example is furnished
by a recent measurement on the excitation function of
the 124Te(p, n)124I reaction [24]. Due to rather poor ex-
isting data at Ep ≤ 12 MeV, this reaction was considered
to be unsuitable for production of 124I. The new meas-
urements [24] showed that the threshold of the reaction
is about 2.5 MeV lower. Hence this process can be con-
veniently used for the production of 124I at a small-sized
cyclotron.
Influence of increasing incident particle energy
It is known that with increasing incident particle energy
the number of competing reaction channels increases; the
need of nuclear data, therefore, increases correspondingly.
Of more significance are the reactions leading to the forma-
tion of isotopic impurities, since the non-isotopic impurities
can be removed by a chemical separation. As an example,
the data for the 75As(p, xn)75,73,72Se reactions [25, 26] are
shown in Fig. 3. For the production of the β+ emitting
73Se (T1/2 = 7.1 h) the energy region Ep = 40 → 30 MeV
appears to be most useful. Over this energy range the
yield of 73Se amounts to 1400 MBq/µA h and the level
of 72,75Se impurity to < 0.2%. Evidently, the higher the
projectile energy is, the more are the data needs. At high
energies (Ep > 200 MeV) the spallation process occurs.
It leads to a large number of products. The data needs
are high, and the chemical processing effort involved is
extensive.
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Fig. 3. Excitation functions of 75As(p, xn)75,73,72Se nuclear reactions,
depicting the influence of the increasing projectile energy. The opti-
mum energy range for the production of 73Se is Ep = 40 → 30 MeV.
Diagram adopted from [26].
Isomeric impurities
The commonly used cyclotron radionuclides (positron emit-
ters, SPECT radioisotopes like 123I, 201Tl, etc.) are isotopes
without any other measurable isomeric state. Many of the
potentially interesting research related radionuclides, on the
other hand, consist of two isomeric states. If one of the states
is short-lived and decays out by the time of application of the
longer-lived isomer, there is no problem. However, if only
the shorter-lived isomer is of interest, there may be some
difficulty in resolving the decay curves and keeping the radi-
ation dose to the minimum level. Two interesting examples
which have emerged in recent years are 94m,gTc and 120m,gI.
Fig. 4. Excitation functions of 94Mo(p, xn)-processes leading to the
formation of 94mTc, 94gTc, 93mTc and 93m,gTc. The optimum energy
range for the production of 94mTc is Ep = 13 → 7 MeV; the isomeric
impurity 94gTc, however, cannot be altogether eliminated. Diagram
adopted from [27].
In the former case the metastable state 94mTc(T1/2 = 53 min)
is interesting and the ground state 94gTc(T1/2 = 4.9 h) is
the disturbing radionuclide. In the latter case, the ground
state 120gI(T1/2 = 1.4 h) is important and the metastable state
120mI(T1/2 = 53 min) disturbs. The two radionuclides of in-
terest can be produced via various routes. In each case it is
important to know the isomeric cross section ratio.
The measured excitation functions of the
94Mo(p, n)94m,gTc and 94Mo(p, 2n)93m,gTc reactions [27] are
shown in Fig. 4. Whereas the isotopic impurities 93m,gTc
can be eliminated from 94m,gTc by a careful selection of the
proton energy range within the target, even over the opti-
mum energy range of Ep = 13 → 7 MeV the 94gTc/94mTc
ratio is constant at 0.07, i.e. the 7% 94gTc impurity cannot
be eliminated. A change in the ratio was effected only by the
use of another nuclear reaction, e.g. 93Nb(3He,2n)94m,gTc or
92Mo(α, pn)94m,gTc. In the case of the isomeric pair 120m,gI,
three reactions, namely 122Te(p, 3n)120m,gI, 120Te(p, n)120m,gI
and 120Te(d, 2n)120m,gI, were investigated. The level of
the 120mI impurity in 120gI was found to be the lowest in
the 120Te(p, n)-process [28]. Evidently, the development
of new radioisotopes, especially if they contain isomeric
states, involves considerable amount of fundamental nuclear
chemistry work.
3.2.5 Status of cross section data and integral tests
In comparison to the data for radionuclide production via
neutron induced reactions in a nuclear reactor, the data for
charged particle induced reactions at cyclotrons and acceler-
ators have not been evaluated in much detail. Although the
body of available data is not small [cf. 29, 30], not much
effort has been devoted to the evaluation methodology of
charged particle data. Only recently the most common reac-
tions for the production of widely used β+ and γ -emitters
have been considered in the framework of an IAEA Coor-
dinated Research Programme (CRP). Theory was found to
be of limited use, so the major emphasis was on fitting pro-
cedures. The thus evaluated data are now available for the
reactions considered [14, 21]. Data testing via integral yield
measurements under well-defined conditions should be the
next step. This has, however, so far not been done.
Besides the well-established diagnostic radionuclides,
several non-conventional, research type radionuclides are
gaining enhanced worldwide attention [cf. 31]. The develop-
ment of production methods of those radionuclides demands
detailed nuclear data work, covering both experimental in-
vestigations and nuclear model calculations.
3.3 Role of nuclear model calculations
Nuclear model calculations are of considerable interest in
medical radioisotope production programmes, in particular
with regard to their predictive power in case of unknown
cross sections. In the energy region up to 20 MeV, the statis-
tical model using the Hauser-Feshbach formalism has been
very successful. At higher energies the precompound-hybrid
model has been commonly applied.
The reactor production of radionuclides involves neu-
tron induced reactions up to 20 MeV. Most of the reaction
cross sections can be described fairly well by the theory.
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As far as unknown cross sections are concerned, the predic-
tive power of the theory, especially in combination with the
known cross section systematics, is high. In the case of cy-
clotron production of radionuclides, a large number of reac-
tion channels in various mass regions are involved. Nuclear
model calculations are only partly successful in reproduc-
ing the production cross sections. In the light mass region,
for example, which is of paramount importance in PET, the-
ory cannot help. In the medium and heavy mass regions, on
the other hand, especially the (p, xn) and (d, xn) reaction
products can be described very well up to incident particle
energies of about 50 MeV (cf. contribution by Shubin, this
issue). In particular, the calculated data may be useful in
adjusting the reaction thresholds since many of the experi-
mental curves are rather erroneous near the thresholds (see
above). In case of other reactions, such as (p, α), (d, pxn),
(3He,xn), (α, xn) etc., considerable deviations may occur
between experimental and calculated data [cf. 32, 33]. At
energies above 50 MeV, even the simple (p, xn) and (d, xn)
reactions are not reproduced well by the theory. On the other
hand, it needs to be emphasized that the calculated data
may have sufficient accuracies in connection with neutron
and proton therapy (cf. contribution by Chadwick, this is-
sue). The accuracies required in the isotope production work
are more stringent and hence more emphasis is placed on
experimental data.
In contrast to total cross section of a reaction channel, the
calculation of a partial cross section, i.e. the probability of
formation of an isomeric state, is more demanding since full
information on nuclear structure has to be fed in. The ex-
citation functions for the formation of isomeric impurities,
therefore, cannot be predicted by theory only, and support-
ing experimental studies are essential. As an example, the
results [34] for the isomeric pair 120m,gI are shown in Fig. 5.
The σm/σg ratio in the 122Te(p, 3n)120m,gI-reaction was de-
termined experimentally and also calculated using the code
STAPRE. The ground state (T1/2 = 1.4 h) has a spin (2+);
the spin of the metastable state (T1/2 = 53 min), however, is
not known with certainty. The calculated results for various
spin values of the metastable state suggest that its true spin is
Fig. 5. Isomeric cross section ratio (σm/σg) for the isomeric pair 120m,gI
in 122Te(p,3n)-reaction as a function of proton energy. Experimen-
tal data are shown as symbols and theoretical results as curves. The
calculational results appear to be strongly dependent on the excita-
tion energy of the metastable state, its spin and parity. Diagram taken
from [34].
probably (4+) or (4−). Best results were obtained by assum-
ing the energy of the metastable state as 550 keV (as against
900 keV given in the literature) and its spin as (4+). With the
latter two assumptions the σm/σg ratio could be reproduced
also in 120Te(p, n)120m,gI and 120Te(d, 2n)120m,gI processes. In
medical radioisotope development work involving formation
of isomeric states, therefore, besides careful experimental
work, also a detailed knowledge of the level structure is
required to be able to perform reliable nuclear model calcu-
lations to verify and validate the measured data.
4. Conclusions
Nuclear data play a very important role in the choice and
medical application of a radioisotope. The nuclear struc-
ture and decay data determine the suitability of a radioiso-
tope for diagnostic application and the reaction cross sec-
tion data its possibility of production in a pure form. Both
reactors and cyclotrons are used for production purposes.
The cross section data for reactor production are generally
well-known and can be satisfactorily reproduced by nuclear
model calculations. The cyclotron production, on the other
hand, demands an extensive database, which is rather good
in the case of the commonly used β+ and single photon
emitting radionuclides. The production of non-conventional
radionuclides, however, puts some demands on data meas-
urements as well as technical and radiochemical develop-
ments. In this context, longer-lived β+ emitters are gaining
increasing importance. Many of the new radionuclides under
consideration consist of two or more isomeric states. De-
tailed measurements on isomeric cross section ratios in all
the possible reaction channels are necessary to be able to
choose a process which gives the lowest isomeric impurity.
Nuclear model calculations can reproduce the experimental
data on (p, xn) and (d, xn) reactions on medium mass tar-
get nuclei in the projectile energy range from threshold up
to about 50 MeV. All the reactions in the light mass region,
uncommon reactions (like (p, α)) in various mass regions,
and isomeric cross section ratios cannot be properly treated
by the theory. In all those cases experimental studies are
mandatory.
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